Nxu announced it is progressing towards closing its merger with Verde Bioresins. On February 11, 2025, approximately 99% of the votes cast by Nxu‘s shareholders approved the issuance of shares of Nxu common stock in connection with and change of control resulting from the contemplated merger, and both Nxu and Verde have been through remaining closing items. Completion of the merger is subject to satisfaction of conditions, including Nasdaq approval. “We have been working through the necessary technicalities closely with both Verde and Nasdaq’s listing department, and we intend to close very soon,” said Mark Hanchett, Chairman and CEO at Nxu. “Completing the recent reverse stock split was a key open item required to position the combined company for success upon close.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NXU:
